A Sphingosine-1-Phosphate Lyase Mutation Associated With Congenital Nephrotic Syndrome and Multiple Endocrinopathy

Background: Loss of function mutations in SGPL1 are associated with Sphingosine-1-phosphate lyase insufficiency syndrome, comprising steroid resistant nephrotic syndrome, and primary adrenal insufficiency (PAI) in the majority of cases. SGPL1 encodes sphingosine-1-phosphate lyase (SGPL1) which is a major modulator of sphingolipid signaling. Case Presentation: A Pakistani male infant presented at 5 months of age with failure to thrive, nephrotic syndrome, primary adrenal insufficiency, hypothyroidism, and hypogonadism. Other systemic manifestations included persistent lymphopenia, ichthyosis, and motor developmental delay. Aged 9 months, he progressed rapidly into end stage oligo-anuric renal failure and subsequently died. Sanger sequencing of the entire coding region of SGPL1 revealed the novel association of a rare homozygous mutation (chr10:72619152, c.511A>G, p.N171D; MAF−1.701e-05) with the condition. Protein expression of the p.N171D mutant was markedly reduced compared to SGPL1 wild type when overexpressed in an SGPL1 knockout cell line, and associated with a severe clinical phenotype. Conclusions: The case further highlights the emerging phenotype of patients with loss-of-function SGPL1 mutations. Whilst nephrotic syndrome is a recognized feature of other disorders of sphingolipid metabolism, sphingosine-1-phosphate lyase insufficiency syndrome is unique amongst the sphingolipidoses in presenting with multiple endocrinopathies. Given the multi-systemic and progressive nature of this form of PAI/ nephrotic syndrome, a genetic diagnosis is crucial for optimal management and appropriate screening for comorbidities in these patients.

[1]  K. Setchell,et al.  Disarranged Sphingolipid Metabolism From Sphingosine-1-Phosphate Lyase Deficiency Leads to Congenital Nephrotic Syndrome , 2019, Kidney international reports.

[2]  Youn-Jeong Choi,et al.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism. , 2019, Advances in biological regulation.

[3]  F. Faucz,et al.  SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency. , 2018, The Journal of clinical endocrinology and metabolism.

[4]  L. Weber,et al.  A novel mutation in sphingosine-1-phosphate lyase causing congenital brain malformation , 2018, Brain and Development.

[5]  S. Pena,et al.  Nephrotic syndrome and adrenal insufficiency caused by a variant in SGPL1 , 2017, Clinical kidney journal.

[6]  Y. Frishberg,et al.  Deficiency of the sphingosine‐1‐phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications , 2017, Human mutation.

[7]  K. Schwarz,et al.  Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency , 2017, The Journal of clinical investigation.

[8]  T. Hornemann,et al.  Sphingosine 1-phosphate lyase deficiency causes Charcot-Marie-Tooth neuropathy , 2017, Neurology.

[9]  L. Metherell,et al.  Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome , 2017, The Journal of clinical investigation.

[10]  A. Fornoni,et al.  Podocyte Pathology and Nephropathy – Sphingolipids in Glomerular Diseases , 2014, Front. Endocrinol..

[11]  C. Barwick,et al.  A rare cause of primary adrenal insufficiency , 2014 .

[12]  J. Saudubray,et al.  Endocrine manifestations related to inherited metabolic diseases in adults , 2012, Orphanet Journal of Rare Diseases.

[13]  M. Sewer,et al.  The interplay between bioactive sphingolipids and steroid hormones , 2010, Steroids.

[14]  Kamran Rizzolo,et al.  The PDGF signaling pathway controls multiple steroid-producing lineages. , 2008, Genes & development.